LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Arthur Klausner will participate on a panel at the Biotechnology Entrepreneurship Boot Camp program that is associated with the the BIO International Convention in San Diego, CA
News | 06. 17. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.